News
9h
India Today on MSNCancer Daily Horoscope Today (June 21 – July 22) July 25, 2025: Performance will be excellent!It also outperformed major romantic releases like Rocky Aur Rani Kii Prem Kahaani (Rs 11.1 crore), Kabir Singh (Rs ...
9h
India Today on MSNGemini Daily Horoscope Today (May 21- June 20), July 25, 2025: Personality will be attractive!The atmosphere around you will be pleasant. Meetings with loved ones will leave a strong impression. Dear ones will be happy. Romantic relationships will be favourable. Opportunities for outings and ...
Pisces (Feb. 19-March 20): Save nothing for later. If you don’t take advantage of what comes your way, someone else will ...
9h
YourTango on MSNYour Daily Horoscope For Friday, July 25 — The Moon Aligns With Mercury RetrogradeEach zodiac sign's daily horoscope is here for Friday, July 25, 2025. The Sun and Moon are both in Leo; however, the main ...
Kneecap, who were scheduled to play a set at Sziget’s closing day on August 11, have faced the cancellation of several of ...
What’s most surprising is that series director and writer Kotaro Uchikoshi is only involved in a supervisory role, leaving ...
Shore Bancshares (SHBI) delivered earnings and revenue surprises of +24.39% and +5.08%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
2h
Zacks.com on MSNCompared to Estimates, PCB Bancorp (PCB) Q2 Earnings: A Look at Key MetricsThe headline numbers for PCB Bancorp (PCB) give insight into how the company performed in the quarter ended June 2025, but it may be worthwhile to compare some of its key metrics to Wall Street ...
Virgo season gets going from August 23, with a New Moon just after sunrise on this day, which is intense – and reminiscent of ...
Now, more than two years after McClain’s conviction in the historic “ComEd Four” bribery case, McClain is scheduled to learn ...
Second quarter earnings season is in full swing, and the results have been largely positive so far, with more positive ...
Group net sales grow by 6.3%* to EUR 14.0 billion, driven by Human Pharma (EUR 11.3 billion) and Animal Health (EUR 2.6 billion)Regulatory submissions underway for zongertinib and nerandomilast, with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results